Systematic review of 13 mostly observational studies (150,630 participants) with meta-analysis: metformin (MD -0.65 mm/year) and sulfonylureas (MD -0.35 mm/year) were associated with slower abdominal aortic aneurysm growth; DPP-4 inhibitors were non-significant.
Meta-analysisn = 150,630
Park et al. Associations of antidiabetic medications with abdominal aortic aneurysm growth and clinical outcomes: A systematic review and meta-analysis